Neuroscience Institute Clinical Trials
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Conditions: Pediatric Migraine.
Principal Investigator: Wilson Heredia Nunez.
Study ID: NEU23013 (C4951002-BHV3000-311) | View Study Details
Humanitarian Device Exemption (Dystonia IRB)
Conditions: Dystonia.
Principal Investigator: Toba Niazi.
Study ID: NEU99202 (H020007) | View Study Details
Focal Cerebral Arteriopathy Steroid Trial (FOCAS)
Conditions: Pediatric Stroke, Arteriopathy, Arterial Ischemic Stroke.
Principal Investigator: Anuj Jayakar.
Study ID: NEU23170 (FOCAS) | View Study Details
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Conditions: Dravet Syndrome.
Principal Investigator: Matt Lallas.
Study ID: NEU24048 (STK-001-DS-301) | View Study Details
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
Conditions: Brain Tumor.
Principal Investigator: Toba Niazi.
Study ID: NEU23134 (BT016) | View Study Details
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy (EXPAND)
Conditions: Childhood Absence Epilepsy, Juvenile Absence Epilepsy.
Principal Investigator: Anuj Jayakar.
Study ID: NEU23003 (N01269) | View Study Details
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex (EpiCom)
Conditions: Tuberous Sclerosis Complex Associated Neuropsychiatric Disease.
Principal Investigator: Paula Schleifer.
Study ID: NEU23103 (JZP926-402) | View Study Details
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects with AS (Aspire)
Conditions: Angelman Syndrome.
Principal Investigator: Paula Schleifer.
Study ID: NEU24001 (GTX-102-CL301) | View Study Details
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine (OASIS(EM))
Conditions: Migraine.
Principal Investigator: Wilson Heredia Nunez.
Study ID: NEU23101 (20150125) | View Study Details
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Conditions: Dyskinesia, Cerebral Palsy.
Principal Investigator: Migvis Monduy.
Study ID: NEU99201 (NBI-98854-DCP3018) | View Study Details
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Conditions: Childhood Absence Epilepsy' Juvenile Absence Epilepsy.
Principal Investigator: Anuj Jayakar.
Study ID: NEU24007 (EP0224) | View Study Details